Novocure Ltd Ord Sh
(NVCR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NVCR | AZN | AMGN | GILD | BMY |
| Company | Novocure Ltd Ord Sh | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 10.34 | 190.46 | 369.99 | 149.69 | 60.00 |
| High | 10.37 | 191.21 | 377.00 | 150.50 | 61.86 |
| Low | 9.93 | 188.49 | 368.90 | 148.71 | 59.77 |
| Latest | 10.05 | 189.40 | 375.49 | 149.49 | 61.12 |
| Change | -0.04 | +2.24 | +7.69 | +0.12 | +1.60 |
| % Change | -0.40% | +1.20% | +2.09% | +0.08% | +2.69% |
| Volume | 343,899 | 617,382 | 457,388 | 1,553,459 | 3,776,730 |
| 20-Day Average Volume | 1,325,979 | 8,719,916 | 2,908,183 | 7,763,661 | 12,747,679 |
| Previous Close | 10.09 | 187.16 | 367.80 | 149.37 | 59.52 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 12.85 | 116.90 | 342.59 | 134.39 | 55.93 |
| 20-Day Raw Stochastic | 4.50% | 96.91% | 95.93% | 98.76% | 87.25% |
| 20-Day Relative Strength | 30.74 | 88.38 | 68.89 | 75.52 | 71.55 |
| Weighted Alpha | -53.07 | +68.67 | +36.53 | +62.69 | +20.53 |
| Today's Opinion | 88% Sell | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 56% Sell | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 8% Buy | 100% Buy | 96% Buy | 72% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -18.87% since 01/30/26 | +104.35% since 01/30/26 | +9.59% since 01/30/26 | +5.75% since 01/30/26 | +10.45% since 01/30/26 |
| Low | 9.82 on 02/05/26 | 183.63 on 02/03/26 | 338.59 on 02/03/26 | 140.01 on 02/02/26 | 54.96 on 02/02/26 |
| High | 12.91 on 02/03/26 | 192.79 on 02/02/26 | 377.00 on 02/06/26 | 150.50 on 02/06/26 | 61.86 on 02/06/26 |
| 1-Month | |||||
| %Chg | -29.60% since 01/06/26 | +99.64% since 01/06/26 | +13.48% since 01/06/26 | +23.69% since 01/06/26 | +11.72% since 01/06/26 |
| Low | 9.82 on 02/05/26 | 89.04 on 01/21/26 | 319.79 on 01/13/26 | 119.33 on 01/09/26 | 53.54 on 01/21/26 |
| High | 15.15 on 01/09/26 | 192.79 on 02/02/26 | 377.00 on 02/06/26 | 150.50 on 02/06/26 | 61.86 on 02/06/26 |
| 3-Month | |||||
| %Chg | -10.74% since 11/06/25 | +126.31% since 11/06/25 | +18.72% since 11/06/25 | +21.65% since 11/06/25 | +30.39% since 11/06/25 |
| Low | 9.82 on 02/05/26 | 84.22 on 11/07/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 15.15 on 01/09/26 | 192.79 on 02/02/26 | 377.00 on 02/06/26 | 150.50 on 02/06/26 | 61.86 on 02/06/26 |
| 6-Month | |||||
| %Chg | -11.68% since 08/06/25 | +157.58% since 08/06/25 | +31.62% since 08/06/25 | +36.12% since 08/06/25 | +35.65% since 08/06/25 |
| Low | 9.82 on 02/05/26 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 15.15 on 01/09/26 | 192.79 on 02/02/26 | 377.00 on 02/06/26 | 150.50 on 02/06/26 | 61.86 on 02/06/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,129,899 | 290,267,936 | 198,053,312 | 185,320,384 | 121,168,016 |
| Shares Outstanding, K | 111,982 | 1,550,908 | 538,481 | 1,240,680 | 2,035,753 |
| Annual Sales | 605,220,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 48,300,000,000 |
| Annual Net Income | -168,630,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -8,948,000,000 |
| Last Quarter Sales | 167,200,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 12,222,000,000 |
| Last Quarter Net Income | -37,270,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 2,201,000,000 |
| 60-Month Beta | 0.73 | 0.34 | 0.46 | 0.36 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.33 on 10/30/25 | 1.19 on 11/06/25 | 5.29 on 02/03/26 | 2.47 on 10/30/25 | 1.26 on 02/05/26 |
| Latest Earnings Date | 02/26/26 | 02/10/26 | 05/07/26 | 02/10/26 | 02/05/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.51 | 16.76 | 17.85 | 8.78 |